European 2,5-Dimethyl-2,4-Hexadiene Market size is projected to surpass USD 55.5 thousand by 2026, according to a latest forecast report by Graphical Research. Market growth is underpinned by rising research activities for new pharmaceutical products and the increasing need for insecticides in the region.
2,5-Dimethyl-2,4-hexadiene finds its major applications in the production of insecticides. The shifting focus on increasing the agricultural output due to rising population and limiting arable lands is generating the need for insecticides. The EU registered sales of pesticides to be around 360 million kg per year between 2011 and 2018. Countries that recorded the highest consumption of these pesticides include France, Spain, Italy, and Germany. These nations accounted for more than two-thirds of the pesticide consumption in the EU and together represent 51% and 49% of the total utilized agricultural area and arable land respectively in the EU. A substantial amount of pesticide usage has been recorded in recent years in Europe and the trend is anticipated to continue.
Browse detailed statistical insights from the report, “Europe 2,5-Dimethyl-2,4-Hexadiene Market Size By Application (Production of 9-chloroanthracene, Insecticides, Others), Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2020 – 2026” along with the table of contents (ToC) @
Another key application of 2,5-dimethyl-2,4-hexadiene is in the synthesis of 9-chloroanchracene and as pharmaceutical intermediates. 9-Chloroanchracene is utilized as a chlorinated anthracene compound that finds usage as pharmaceutical intermediates and in biochemical reactions. Additionally, 2,5-dimethyl-2,4-hexadiene has potential application in biomarker testing to detect lung cancer and helps in determining a unique set of medication for cancer patients. Since, Europe consists of one of the highly organized healthcare sectors and has been witnessing significant investments in research & development activities, the demand for 2,5-dimethyl-2,4-hexadiene is certain to increase in the coming years.
On the other hand, the COVID-19 pandemic health crisis resulted in the closure of material production facilities for some weeks, resulting in a major demand-supply gap of raw materials across Europe. Product demand for agricultural applications has experienced a substantial decline. However, demand from the healthcare industry has been improved owing to the increasing number of ongoing research activities in the field.
Additionally, market participants are adopting strategic initiatives to bolster their industry foothold. The initiatives taken by key players include production capacity expansion, mergers, acquisitions, and strategic partnerships. For instance, Merk Group acquired Sigma-Aldrich Co. to obtain more market share in the life science segment in conjunction with the development of e-commerce platforms across the globe.
Some of the major manufacturers of 2,5-dimethyl-2,4-hexadiene operating in the European region include Sigma-Aldrich Co., Tokyo Chemical Industry Co., Ltd. (TCI), Santa Cruz Biotechnology, Inc., Manchester Organics Ltd., abcr GmbH, and Alfa Aesar.
The European 2,5-dimethyl-2,4-hexadiene market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2015 to 2026 for the following segments:
Europe Market, By Application
- Production of 9-chloroanthracene
The above information has been provided for the following countries:
- Rest of Europe